Sequenom ( SQNM) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day down 1.8%. By the end of trading, Sequenom rose 12 cents (2.3%) to $5.40 on heavy volume. Throughout the day, 14.2 million shares of Sequenom exchanged hands as compared to its average daily volume of 3.2 million shares. The stock ranged in a price between $5.05-$5.83 after having opened the day at $5.10 as compared to the previous trading day's close of $5.28. Other companies within the Drugs industry that increased today were: Cormedix ( CRMD), up 16.7%, Opexa Therapeutics ( OPXA), up 15.1%, Aoxing Pharmaceutical Company ( AXN), up 13.9%, and Transition Therapeutics ( TTHI), up 10%. Sequenom, Inc. provides products, services, diagnostic testing, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural and livestock research. Sequenom has a market cap of $614.5 million and is part of the health care sector. Shares are up 18.7% year to date as of the close of trading on Thursday. Currently there are eight analysts that rate Sequenom a buy, no analysts rate it a sell, and four rate it a hold. TheStreet Ratings rates Sequenom as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and unimpressive growth in net income.